FDA Accepts Supplemental Biologics License Application for Genentech's Polivy Combination for People With Previously ...
– First new treatment regimen in more than 20 years to significantly improve outcomes in people with this fast-growing type of lymphoma – – Application is based on pivotal data from the Phase III POLARIX study showing Polivy plus R-CHP significantly …